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Objective: This article serves to review latissimus dorsi myocutaneous ﬂap as an option
for breast reconstruction postmastectomy. Since the introduction of the latissimus dorsi
myocutaneous ﬂap in the late 1970s, its use has always been as a secondary technique,
particularly after the development of the transverse rectus abdominus myocutaneous
ﬂap in the 1980s. Methods: A literature review of the history of latissimus dorsi my-
ocutaneous ﬂap utilized for breast reconstruction as well as a review of our institution’s
experience with latissimus dorsi myocutaneous ﬂap and tissue expander placement
was performed. Results: There remains a paucity of published studies investigating
latissimus dorsi myocutaneous ﬂap for breast reconstruction. Most studies have small
numbers and do not utilize tissue expanders. More recently several small studies have
been published that show acceptably low complication rates with aesthetically pleasing
outcomes when latissimus dorsi myocutaneous ﬂap is employed with a tissue expander.
At our institution, we have employed latissimus dorsi myocutaneous ﬂap with tissue
expander placement for both delayed and immediate reconstruction with subsequent re-
placement with a permanent implant with a capsular contraction rate of 10.5%. Our data
and others more recently published demonstrate very acceptable capsular contracture
ratesandaestheticoutcomes,particularlywhenanexpanderisutilized.Conclusion:The
latissimusdorsimyocutaneous ﬂapremainsanexcellent choiceforbreastreconstruction
with a low risk of complications.
Over 202,000 women were diagnosed with breast cancer in 2007.1 As the US popula-
tion continues to age, the prevalence of breast cancer is expected to continue to increase.
The choice to undergo breast reconstruction is increasingly commonplace and has proven
psychological beneﬁts for many women.2 The type and the timing of reconstruction is a
multifactorial decision based on the need for adjuvant treatment, lifestyle, desired cosmetic
outcome, and preference and experience of the surgeon. As reconstruction has become
more prevalent, the search for the most aesthetically pleasing outcome has become more
pronounced. Over the past several decades breast reconstruction techniques have evolved
from injectionof parafﬁn directlyinto the defect to the current advanced techniquessuch as
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deep inferior epigastric perforator ﬂaps.3 This article discusses the history of the latissimus
dorsi myocutaneous ﬂap (LDMF), its evolution and reviews its published data.
METHODS
A literature review of the history of LDMF utilized for breast reconstruction as well as
a review of our institution’s experience with LDMF and tissue expander placement was
performed.
RESULTS
The LDMF was ﬁrst described in the late 1800s by Italian surgeon Tanzini4 a san o v e l
approach to repairing breast amputation. It was not until the 1970s however that the
LDMF began to evolve into its current state. Schneider et al5 and Olivari6 described
their experiences with latissimus ﬂaps following mastectomy and radiation in 1977. In
1978, the technique of a skin island over the muscle ﬂap was promoted by Bostwick
et al.7 Bostwick et al7,8 described utilization of the LDMF with and without silicone pros-
thesis. Later, Maxwell argued that the ﬂap could be utilized even if surgeons sacriﬁced
the main thoracodorsal trunk as the ﬂap could be sustained by collateral circulation.9 This
collateral circulation was found by Fisher to be from reversed ﬂow of the serratus branch
of the thoracodorsal artery.10
In early series, LDMF was heavily criticized for high capsular contracture rates and
other complications such as seroma formation.11-14 Also, in the early 1980s, Hartrampf
et al15 popularized the transverse rectus abdominus myocutaneous (TRAM) ﬂap. The
TRAM ﬂap quickly became the ﬁrst choice for many patients considering breast recon-
struction, even though it was a more extensive surgery with a longer recovery period and
had signiﬁcant complications. With this rise in the popularity of TRAM ﬂaps, together with
the bad rap for high capsular contracture rates, LDMF was relegated to a secondary choice.
As stated, the most signiﬁcant criticism has been the LDMF’s reported incidence of
capsularcontracture(7.4%-75%).11-14ThemajorityofthedataonLDMFcomplicationrates
however are based on small series that are both antiquated and biased.12-14 Furthermore,
upon review of the published series, the majority of papers utilized an implant with the
ﬂap as the deﬁnitive reconstruction rather than an expander. For example, DeMey et al13
reviewed 103 cases of LDMF with permanent implant placement. They noted clinically
signiﬁcantcapsularcontracturesin26%ofpatients.Again,notissueexpanderswereutilized
prior to permanent implant. Kroll et al14 compared LDMF (n = 16) to TRAM (n = 66)
in previously irradiated patients. There was a much higher complication rate in the LDMF
group (63% versus 33%). Again, no patients in this study had tissue expanders placed prior
to permanent implant placement.
McCraw and Maxwell12 reported the results of 82 patients who had undergone LDMF
for breast reconstruction. Permanent implants were used in all patients. The patients were
split into 2 groups—radical mastectomy and modiﬁed radical mastectomy. A capsular
contracture rate of 75% was noted in the radical mastectomy group and of 39% in the
modiﬁed radical mastectomy group.12 Corrective surgery was required in 44 and 40 cases,
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respectively.12 The authors noted that tissue expander placement would have perhaps de-
creased their capsular contracture rate.
More recently, however, Venus and Prinsloo11 reported a small series (n = 38) of
immediate latissimus dorsi plus permanent implant reconstructions in 2008. Their survey
focused primarily on patient satisfaction at a mean follow-up time of 3.2 years, but they
did note a low capsular contracture rate requiring surgery of 7.4% and a seroma rate of
20.4%.11 Also in 2008, Hankins and Friedman16 reported a small series of LDMF plus
permanent implant reconstruction that had a total complication rate of 27% with 2 of their
37 patients developing capsular contracture.
There continues to be a dearth of literature investigating LDMF breast reconstruction
in conjunction with initial placement of tissue expanders rather than an implant. Abdalla
et al17 published a series of 25 women who underwent immediate LDMF reconstruction
with tissue expander placement after skin sparing mastectomy.17 They reported skin ﬂap
necrosis in 12% and wound infection in 4%; no mention was made of capsular contracture.
Mast and Simoneau18 describe a capsular contracture rate of 8% in 32 patients with LDMF
reconstructionwithtissueexpanderandsubsequentpermanentimplantplacement.Another
small series of 32 consecutive patients from Sweden investigated patient satisfaction with
LDMF ﬂap alone (n = 8), with tissue expanders (n = 13), and with permanent implants
(n = 11).19 Their median follow-up time was 35 months, and they noted 9 of 26 patients
developed seromas without mention of capsular contracture rates.19 Patients overall were
satisﬁed with aesthetic appearance.19
There is variation in published complication rates in LDMF in irradiated breasts
as well. Garusi et al20 reported a 3.1% Baker’s Class III capsular contracture rate in 63
patients who had LDMF with permanent implant reconstruction after irradiation. Spear
et al21 conducted a retrospective review of 28 patients after irradiation, 18 of whom had
LDMF with tissue expander and 10 of whom had LDMF with permanent implant.21 They
reportedacapsularcontracturerateof3.5%andaseromarateof17.8%(5of28patients).21
Changetal22 publishedanextensivereviewof1000reconstructionsofpreviouslyirradiated
breasts with various reconstructive methods. They reported a total capsular contracture rate
for LDMF of 6.4% in breasts that did not receive radiation and 3% in those that received
preoperative radiation.22 However, the LDMF ﬂaps they studied also employed permanent
implants rather than tissue expanders. All in all, the data remain clouded by consisting
mainly of small series.
DISCUSSION
At our institution, we have employed LDMF with tissue expander placement for both
delayed and immediate reconstruction with subsequent replacement with a permanent
implant (Fig 1). We published a review of our experience with 100 patients who underwent
LDMFwithtissueexpandersanddemonstratedacapsularcontracturerateof6%.23 Wealso
published our experience with LDMF following mastectomy for failed lumpectomy and
radiation. Even in this irradiated group, when an expander is used, the capsular contracture
rate is 12%.24 More recently, our review of more than 200 patients including radiated and
nonradiatedbreastsconﬁrmsalowcapsularcontracturerateofanygradeof10.5%.Seroma,
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both donor site and breast, remains signiﬁcant (24.5%). This rate remains consistent with
previously published studies.13
Figure 1. A patient a few days after skin sparing mastectomy and immedi-
ate breast reconstruction. The bolsters are utilized for inset of the latissimus
dorsi muscle in the inframammary fold.
Aesthetically,apleasingoutcomeisobtainablewithLDMFreconstructionwhentissue
expandersareemployed(Figs2and3).Theadvantageofthisoperationisthatitistechnically
straightforward and hospitalization is an average of 2 days, which compares favorably with
theTRAMﬂap.Transverserectusabdominusmyocutaneousalsohasanarguablyhigherrate
of both overall complications and signiﬁcant complications such as hernias, fat necrosis,
etc.25-28
Figure 2. A patient after delayed reconstruction of right breast with latissimus dorsi
myocutaneous ﬂap.
In summary, LDMF for breast reconstruction after mastectomy is a procedure that
has been erroneously maligned over the years for high capsular contracture complications.
In reality, a lot of the data regarding capsular contracture rates in LDMF are outdated
and skewed. Proper study of LDMF most likely was hindered by the rapid rise in the
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popularityoftheTRAMﬂapintheearly1980s.Ourdataandothersmorerecentlypublished
demonstrateveryacceptablecapsularcontractureratesandaestheticoutcomes,particularly
when an expander is utilized. We believe that LDMF should be utilized more often, as it is
a technically straightforward procedure that gives acceptable cosmetic outcomes with few
complications.
Figure 3. A patient following reconstruction of the left breast with latissimus dorsi
myocutaneous ﬂap and expander following a failed deep inferior epigastric perforator
ﬂap (DIEP) ﬂap. The right side was reconstructed with a DIEP ﬂap.
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